References
- Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. New Engl J Med. 2011;365:395–409.
- Bo L, Li C, Pan L, et al. Diagnosing a solitary pulmonary nodule using multiple bronchoscopic guided technologies: a prospective randomized study. Lung Cancer. 2019;129:48–54.
- Jiang S, Xie F, Mao X, et al. The value of navigation bronchoscopy in the diagnosis of peripheral pulmonary lesions: a meta-analysis. Thorac Cancer. 2020;11(5):1191–1201.
- Wang MJ, Nietert PJ, Silvestri GA. Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest. 2012;142(2):385–393.
- Ettinger DS, Wood DE, Aisner DL, et al. NCCN guidelines insights: non-small cell lung cancer, version 2.2021. J Natl Compr Canc Ne. 2021;19(3):254–266.
- Papadimitrakopoulou VA, Han JY, Ahn MJ, et al. Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer. Cancer-Am Cancer Soc. 2020;126:373–380.
- Ruiz-Cordero R, Devine WP. Targeted therapy and checkpoint immunotherapy in lung cancer. Surg Pathol Clin. 2020;13(1):17–33.
- Valentino F, Borra G, Allione P, et al. Emerging targets in advanced non-small-cell lung cancer. Future Oncol. 2018;14(13s):61–72.
- Frank MS, Bodtger U, Hoegholm A, et al. Re-biopsy after first line treatment in advanced NSCLC can reveal changes in PD-L1 expression. Lung Cancer. 2020;149:23–32.
- Bo L, Shi L, Jin F, et al. The hemorrhage risk of patients undergoing bronchoscopic examinations or treatments. Am J Transl Res. 2021;13(8):9175–9181.
- Deng CJ, Dai FQ, Qian K, et al. Clinical updates of approaches for biopsy of pulmonary lesions based on systematic review. Bmc Pulm Med. 2018;18(1):146.
- Sidhu JS, Salte G, Christiansen IS, et al. Fluoroscopy guided percutaneous biopsy in combination with bronchoscopy and endobronchial ultrasound in the diagnosis of suspicious lung lesions - the triple approach. Eur Clin Respir J. 2020;7(1):1723303.
- Kato A, Yasuo M, Tokoro Y, et al. Virtual bronchoscopic navigation as an aid to CT-guided transbronchial biopsy improves the diagnostic yield for small peripheral pulmonary lesions. Respirology. 2018;23(11):1049–1054.
- Arimura K, Tagaya E, Akagawa H, et al. Cryobiopsy with endobronchial ultrasonography using a guide sheath for peripheral pulmonary lesions and DNA analysis by next generation sequencing and rapid on-site evaluation. Respir Investig. 2019;57(2):150–156.
- Qian K, Krimsky WS, Sarkar SA, et al. Efficiency of electromagnetic navigation bronchoscopy and virtual bronchoscopic navigation. Ann Thorac Surg. 2020;109(6):1731–1740.
- Folch EE, Labarca G, Ospina-Delgado D, et al. Sensitivity and safety of electromagnetic navigation bronchoscopy for lung cancer diagnosis: systematic review and meta-analysis. Chest. 2020;158(4):1753–1769.
- Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. New Engl J Med. 2010;362(25):2380–2388.
- Shaw AT, Kim DW, Nakagawa K, et al. Crizotinib versus chemotherapy in advanced ALK -positive lung cancer. New Engl J Med. 2013;368(25):2385–2394.
- Shaw AT, Ou SH, Bang YJ, et al. Crizotinib in ROS1 -rearranged non–small-cell lung cancer. New Engl J Med. 2014;371(21):1963–1971.
- Brose MS, Volpe P, Feldman M, et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002;62(23):6997–7000.
- Reck M, Rodriguez-Abreu D, Robinson AG, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung Cancer. New Engl J Med. 2016;375(19):1823–1833.
- Tateishi A, Matsumoto Y, Tanaka M, et al. The utility of transbronchial rebiopsy for peripheral pulmonary lesions in patients with advanced non-squamous non-small cell lung cancer. Bmc Pulm Med. 2020;20(1):238.